ArticleClinical and translational science2017

A Proton Pump Inhibitor in the Reformulation Setting: Bioequivalence and Potential Implications for Long-Term Safety.

E Dubcenco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.